vs
HERON THERAPEUTICS, INC.（HRTX）与RCI HOSPITALITY HOLDINGS, INC.（RICK）财务数据对比。点击上方公司名可切换其他公司
RCI HOSPITALITY HOLDINGS, INC.的季度营收约是HERON THERAPEUTICS, INC.的1.7倍（$70.9M vs $40.6M），HERON THERAPEUTICS, INC.净利率更高（-7.3% vs -7.8%，领先0.5%），HERON THERAPEUTICS, INC.同比增速更快（-0.5% vs -3.1%），过去两年HERON THERAPEUTICS, INC.的营收复合增速更高（8.2% vs -2.0%）
安提贝制药是一家总部位于多伦多的制药企业，由曾参与创立全球首个气态介质药物开发企业NicOx的约翰·L·华莱士创立于2009年。该企业专注于依托气态介质技术研发缓解疼痛与炎症的药物，2013年在多伦多风险交易所挂牌，2015年收购再生医学领域经销商Citagenix，2020年11月转板多伦多证券交易所。
RCI Hospitality控股通过子公司经营脱衣舞俱乐部、夜总会、运动酒吧与餐厅，同时还运营一家为成人俱乐部行业提供服务的传媒会展企业。公司于1995年完成首次公开募股上市，目前在纳斯达克全球市场挂牌交易。
HRTX vs RICK — 直观对比
营收规模更大
RICK
是对方的1.7倍
$40.6M
营收增速更快
HRTX
高出2.7%
-3.1%
净利率更高
HRTX
高出0.5%
-7.8%
两年增速更快
HRTX
近两年复合增速
-2.0%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $40.6M | $70.9M |
| 净利润 | $-3.0M | $-5.5M |
| 毛利率 | 72.6% | — |
| 营业利润率 | 0.1% | -0.7% |
| 净利率 | -7.3% | -7.8% |
| 营收同比 | -0.5% | -3.1% |
| 净利润同比 | -180.6% | -2354.9% |
| 每股收益（稀释后） | $-0.01 | $-0.60 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收HRTXRICK
| Q4 25 | $40.6M | — | ||
| Q3 25 | $38.2M | $70.9M | ||
| Q2 25 | $37.2M | $71.1M | ||
| Q1 25 | $38.9M | $65.9M | ||
| Q4 24 | $40.8M | $71.5M | ||
| Q3 24 | $32.8M | $73.2M | ||
| Q2 24 | $36.0M | $76.2M | ||
| Q1 24 | $34.7M | $72.3M |
净利润HRTXRICK
| Q4 25 | $-3.0M | — | ||
| Q3 25 | $-17.5M | $-5.5M | ||
| Q2 25 | $-2.4M | $4.1M | ||
| Q1 25 | $2.6M | $3.2M | ||
| Q4 24 | $3.7M | $9.0M | ||
| Q3 24 | $-4.8M | $244.0K | ||
| Q2 24 | $-9.2M | $-5.2M | ||
| Q1 24 | $-3.2M | $774.0K |
毛利率HRTXRICK
| Q4 25 | 72.6% | — | ||
| Q3 25 | 68.8% | — | ||
| Q2 25 | 73.5% | — | ||
| Q1 25 | 78.3% | — | ||
| Q4 24 | 74.9% | — | ||
| Q3 24 | 71.2% | — | ||
| Q2 24 | 70.8% | — | ||
| Q1 24 | 75.6% | — |
营业利润率HRTXRICK
| Q4 25 | 0.1% | — | ||
| Q3 25 | -10.7% | -0.7% | ||
| Q2 25 | -4.4% | 12.2% | ||
| Q1 25 | 8.1% | 12.4% | ||
| Q4 24 | 10.2% | 19.5% | ||
| Q3 24 | -13.6% | 4.8% | ||
| Q2 24 | -17.9% | -3.3% | ||
| Q1 24 | -13.8% | 6.4% |
净利率HRTXRICK
| Q4 25 | -7.3% | — | ||
| Q3 25 | -45.8% | -7.8% | ||
| Q2 25 | -6.4% | 5.7% | ||
| Q1 25 | 6.8% | 4.9% | ||
| Q4 24 | 9.0% | 12.6% | ||
| Q3 24 | -14.8% | 0.3% | ||
| Q2 24 | -25.6% | -6.9% | ||
| Q1 24 | -9.1% | 1.1% |
每股收益（稀释后）HRTXRICK
| Q4 25 | $-0.01 | — | ||
| Q3 25 | $-0.10 | $-0.60 | ||
| Q2 25 | $-0.02 | $0.46 | ||
| Q1 25 | $0.01 | $0.36 | ||
| Q4 24 | $0.02 | $1.01 | ||
| Q3 24 | $-0.03 | $0.04 | ||
| Q2 24 | $-0.06 | $-0.56 | ||
| Q1 24 | $-0.02 | $0.08 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $28.6M | $33.7M |
| 总债务越低越好 | — | $238.2M |
| 股东权益账面价值 | $14.3M | $261.1M |
| 总资产 | $255.9M | $596.9M |
| 负债/权益比越低杠杆越低 | — | 0.91× |
8季度趋势，按日历期对齐
现金及短期投资HRTXRICK
| Q4 25 | $28.6M | — | ||
| Q3 25 | $43.1M | $33.7M | ||
| Q2 25 | $16.5M | $29.3M | ||
| Q1 25 | $19.3M | $32.7M | ||
| Q4 24 | $25.8M | $34.7M | ||
| Q3 24 | $25.7M | $32.4M | ||
| Q2 24 | $18.4M | $34.9M | ||
| Q1 24 | $20.4M | $20.0M |
总债务HRTXRICK
| Q4 25 | — | — | ||
| Q3 25 | — | $238.2M | ||
| Q2 25 | — | $243.8M | ||
| Q1 25 | — | $244.1M | ||
| Q4 24 | — | — | ||
| Q3 24 | — | $241.1M | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
股东权益HRTXRICK
| Q4 25 | $14.3M | — | ||
| Q3 25 | $14.9M | $261.1M | ||
| Q2 25 | $-27.3M | $269.5M | ||
| Q1 25 | $-28.5M | $268.8M | ||
| Q4 24 | $-33.7M | $269.0M | ||
| Q3 24 | $-40.0M | $263.4M | ||
| Q2 24 | $-37.9M | $271.2M | ||
| Q1 24 | $-33.8M | $285.8M |
总资产HRTXRICK
| Q4 25 | $255.9M | — | ||
| Q3 25 | $248.9M | $596.9M | ||
| Q2 25 | $232.1M | $597.4M | ||
| Q1 25 | $235.8M | $589.8M | ||
| Q4 24 | $233.1M | $586.2M | ||
| Q3 24 | $220.8M | $584.4M | ||
| Q2 24 | $218.1M | $601.0M | ||
| Q1 24 | $217.9M | $609.9M |
负债/权益比HRTXRICK
| Q4 25 | — | — | ||
| Q3 25 | — | 0.91× | ||
| Q2 25 | — | 0.90× | ||
| Q1 25 | — | 0.91× | ||
| Q4 24 | — | — | ||
| Q3 24 | — | 0.92× | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $-9.2M | $13.7M |
| 自由现金流经营现金流 - 资本支出 | — | $11.5M |
| 自由现金流率自由现金流/营收 | — | 16.2% |
| 资本支出强度资本支出/营收 | 0.0% | 3.2% |
| 现金转化率经营现金流/净利润 | — | — |
| 过去12个月自由现金流最近4个季度 | — | $34.9M |
8季度趋势，按日历期对齐
经营现金流HRTXRICK
| Q4 25 | $-9.2M | — | ||
| Q3 25 | $1.3M | $13.7M | ||
| Q2 25 | $-10.9M | $13.8M | ||
| Q1 25 | $-8.9M | $8.5M | ||
| Q4 24 | $-11.8M | $13.3M | ||
| Q3 24 | $3.4M | $15.7M | ||
| Q2 24 | $-4.6M | $15.8M | ||
| Q1 24 | $-9.5M | $10.8M |
自由现金流HRTXRICK
| Q4 25 | — | — | ||
| Q3 25 | — | $11.5M | ||
| Q2 25 | $-11.1M | $10.1M | ||
| Q1 25 | $-9.0M | $5.7M | ||
| Q4 24 | — | $7.6M | ||
| Q3 24 | $2.9M | $10.3M | ||
| Q2 24 | — | $9.3M | ||
| Q1 24 | — | $3.2M |
自由现金流率HRTXRICK
| Q4 25 | — | — | ||
| Q3 25 | — | 16.2% | ||
| Q2 25 | -29.8% | 14.2% | ||
| Q1 25 | -23.1% | 8.6% | ||
| Q4 24 | — | 10.6% | ||
| Q3 24 | 9.0% | 14.0% | ||
| Q2 24 | — | 12.3% | ||
| Q1 24 | — | 4.4% |
资本支出强度HRTXRICK
| Q4 25 | 0.0% | — | ||
| Q3 25 | 0.0% | 3.2% | ||
| Q2 25 | 0.6% | 5.2% | ||
| Q1 25 | 0.3% | 4.3% | ||
| Q4 24 | — | 8.0% | ||
| Q3 24 | 1.3% | 7.3% | ||
| Q2 24 | — | 8.4% | ||
| Q1 24 | — | 10.6% |
现金转化率HRTXRICK
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | 3.40× | ||
| Q1 25 | -3.37× | 2.65× | ||
| Q4 24 | -3.22× | 1.48× | ||
| Q3 24 | — | 64.14× | ||
| Q2 24 | — | — | ||
| Q1 24 | — | 14.00× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
HRTX
| CINVANTI | $22.9M | 56% |
| ZYNRELEF | $12.5M | 31% |
| Aponvie | $3.8M | 9% |
| SUSTOL | $1.3M | 3% |
RICK
| Transferred At Point In Time | $60.8M | 86% |
| Food And Merchandise | $10.4M | 15% |
